Pembrolizumab therapy leads to resolution of lentigines and tumour control in a patient with xeroderma pigmentosum and advanced cutaneous squamous cell carcinoma
Year: 2026
Type: article
Study design: Case Report
DOI: 10.1093/ced/llag029
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7125510242
